A carregar...
Some Effects of CB1 Antagonists with Inverse Agonist and Neutral Biochemical Properties,
The CB1 inverse agonist/antagonist SR141716A recently has been introduced for the management of obesity (rimonabant; Acomplia) and appears to have beneficial effects. However, its utility may be hampered in some individuals by adverse effects including nausea or emesis or by mood depression. The rec...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2441972/ https://ncbi.nlm.nih.gov/pubmed/18076956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.physbeh.2007.11.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|